Episode 202: The Uromigos Paper of the Month—Docetaxel and Continuous Enzalutamide in CRPC

By The Uromigos - Last Updated: January 30, 2024

The Uromigos chat with Axel Merseburger, MD, PhD, Chairman of the Clinic of Urology at University Hospital Schleswig-Holstein in Lübeck, Germany, about his paper on continuing enzalutamide with docetaxel for the treatment of castration-resistant prostate cancer.

Post Tags:Uromigos-Paper of the MonthUromigos-Prostate Cancer
Advertisement
Advertisement
Advertisement